Records are supplied by study sponsors and investigators. A registry listing is not an endorsement or a guarantee of safety, availability or eligibility.
WCR feed checked: Nov 12, 2026.
Not yet recruitingNCT05425017
Low Back Pain · Healthy
Observational30 years - 75 yearsLombard, Illinois, United States Chiropractic adjustment has been shown to gap certain joints in the spine, thereby improving mobility in individuals with decreased movement capabilities. During normal motion, joints in the spine produce sounds and vibrations called crepitus. The pu…
Active, not recruitingNCT06120491
Metastatic Castration-Sensitive Prostate Cancer
Phase 318 years - 130 yearsChandler, Arizona, United States +274 The intention of the study is to demonstrate superiority of Saruparib (AZD5305) + physician's choice NHA relative to placebo + physician's choice NHA by assessment of radiographic progression-free survival (rPFS) in participants with mCSPC.
RecruitingNCT06002659
B-cell Lymphoma
Phase 1 / Phase 2Not specified - Not specifiedStockholm, Sweden +1 The purpose is to study the safety, tolerability, pharmacokinetics, pharmacodynamics and efficacy of CAR20(NAP)-T for patients with B-cell malignancies.
Not yet recruitingNCT07928089
Sickle Cell Disease
Not applicable18 years - Not specifiedCleveland, Ohio, United States Sickle cell disease causes very painful episodes that can happen without warning. Pain is one of the biggest problems for people with SCD. Medicines like opioids can help, but they have serious side effects. Doctors are looking for other ways to trea…
RecruitingNCT05541341
Diffuse Large B-cell Lymphoma · Acute Lymphoblastic Leukemia · Follicular Lymphoma
Observational0 years - 100 yearsMinas Gerais, Belo Horizonte, Brazil +4 This will be a multicenter, national, non-interventional, prospective cohort study
CompletedNCT03156907
High Dosage Buprenorphine
Phase 218 years - 100 yearsClermont-Ferrand, Auvergne, France The prevalence of analgesics opioids addiction in chronic pain patient is very difficult to know. Many studies indicated that the prevalence of addiction varied from 0% up to 50% in chronic non cancer pain patients, and from 0% up to 7.7% in cancer p…
Not yet recruitingNCT07841730
Diabetic Foot
Not applicable55 years - 75 yearsLocation not listed The purpose of this study is to compare the effects of Tibial Nerve Mobilization and Multisensory Exercises on balance, quality of life, neuropathy severity and healing in patients with Diabetic Foot Ulcers. The aim is to identify the more effective …
Not yet recruitingNCT07565207
Brain Plasticity
Not applicable18 years - 50 yearsLocation not listed Aim 1: Measure local shifts in cortical spectral dynamics following aiTBS. Aim 2: Measure network-specific shifts in task performance following aiTBS. Exploratory aim: Evaluate changes to resting state spectral dynamics in absence of stimulation afte…
RecruitingNCT07870044
Spinal Cord Injury · Stroke · Healthy
Not applicable12 years - 50 yearsBosisio Parini, Lecco, Italy Embodiment is an important aspect of virtual reality because it affects how natural and engaging the experience feels and can influence performance and learning in VR-based applications, including rehabilitation. In VR, embodiment refers to the exten…
By invitationNCT07929103
Temporomandibular Joint Osteoarthritis
Not applicable18 years - Not specifiedCairo, Cairo Governorate, Egypt The goal of this clinical trial is to evaluate the efficacy of intra-articular Vitamin D3 injection for the treatment of temporomandibular joint (TMJ) osteoarthritis. The main questions it aims to answer are: is intra-articular Vitamin D3 injection m…
RecruitingNCT07285213
Clostridioides Difficile Infection
Phase 218 years - Not specifiedPhoenix, Arizona, United States +110 The purpose of this study is to evaluate the efficacy and safety of AZD5148 for prevention of recurrence of Clostridioides difficile infection in Individuals 18 years of age and above.
RecruitingNCT06997588
PIK3CA-related Overgrowth Spectrum (PROS)
Phase 22 years - 100 yearsSacramento, California, United States +38 This study is designed to demonstrate the efficacy and assess safety and tolerability of oral daily alpelisib in participants with PIK3CA-related overgrowth spectrum (PROS).
Retrieved from ClinicalTrials.gov: Nov 12, 2026. Overall study status may differ from a particular location’s status.
